Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
Actual shortage: | 246 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2019-04-25 | 2019-05-28 | 82410 |
TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2019-06-18 | 2019-12-19 | 86859 |
TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2019-06-18 | 2019-12-19 | 86879 |
TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2020-02-21 | 2020-03-05 | 106919 |
TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2020-04-10 | 2020-05-01 | 111803 |
TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2021-05-20 | 2021-05-27 | 139728 |
TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2023-02-02 | 2023-04-28 | 183380 |
TEVA-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2023-11-30 | 2024-02-15 | 211973 |
TEVA-CARVEDILOL | 3.125MG | TABLET | Resolved | 2020-02-21 | 2020-05-01 | 106931 |
TEVA-CARVEDILOL | 25MG | TABLET | Resolved | 2020-03-12 | 2020-03-26 | 108593 |
TEVA-CARVEDILOL | 6.25MG | TABLET | Resolved | 2020-03-26 | 2020-04-23 | 109586 |
TEVA-CARVEDILOL | 12.5MG | TABLET | Resolved | 2020-06-04 | 2020-09-25 | 116687 |
TEVA-CARVEDILOL | 3.125MG | TABLET | Resolved | 2021-06-17 | 2021-07-09 | 141107 |
TEVA-CARVEDILOL | 25MG | TABLET | Resolved | 2022-06-16 | 2022-08-09 | 162852 |
TEVA-CARVEDILOL | 3.125MG | TABLET | Resolved | 2022-11-14 | 2023-02-09 | 174598 |
TEVA-CARVEDILOL | 6.25MG | TABLET | Resolved | 2022-11-14 | 2023-02-09 | 174601 |
TEVA-CARVEDILOL | 3.125MG | TABLET | Actual shortage | 2024-05-09 | 2024-05-16 | 227471 |
TEVA-CARVEDILOL | 6.25MG | TABLET | Actual shortage | 2024-05-09 | 2024-05-16 | 227474 |
TEVA-CEFADROXIL | 500MG | CAPSULE | Resolved | 2019-11-21 | 2020-01-30 | 99426 |
TEVA-CEFADROXIL | 500MG | CAPSULE | Resolved | 2021-08-05 | 2021-12-02 | 143716 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-10-25 | 2019-10-26 | 97251 |
NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
NOVO-PROFEN | 200MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81310 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-12 | 2018-10-12 | 63943 |
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-19 | 2018-10-19 | 64891 |
TEVA-LENOLTEC NO. 1 | 300MG 8MG 15MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81362 |
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 |